Biotech Firm Approved by FDA to Study CBD-Based Drug for Opioid Use Disorder
Mon / Jan 10th
The biotech pharma firm ANANDA Scientific Inc. announced it has received FDA approval to study a CBD-based drug as a treatment for opioid-use disorder.
The US Food and Drug Administration (FDA) is currently working to understand how cannabis and isolated CBD products can be useful to American citizens. There are robust statistics and stories emerging as the FDA conducts cannabis research. Read more about these details in the following stories, and sign up for our newsletter to be the first to find out when news hits the wire.
Mon / Jan 10th
The biotech pharma firm ANANDA Scientific Inc. announced it has received FDA approval to study a CBD-based drug as a treatment for opioid-use disorder.
Tue / Nov 16th
Dr. Robert Califf, President Joe Biden’s pick to head the Food and Drug Administration, has prescribed cannabinoid therapy as a cardiac doctor and actively encourages research into cannabinoid medicine.
Thu / Oct 28th
Louisiana is set to allow Delta-8 THC in food and other edible products following an announcement this week by the state’s Department of Health.
Wed / Oct 13th
California now allows for hemp-derived cannabinoids in everyday products including food and beverages, dietary supplements, cosmetics, and pet food.
Fri / Oct 1st
The Washington State Liquor and Cannabis Board has released a draft proposal that would further regulate “psychotropic” and “impairing” cannabinoids like Delta-8 and Delta-10 THC.
Wed / Sep 15th
The FDA and CDC issued warnings this week against consumer products containing hemp-derived delta-8 THC, which has yet to be thoroughly studied.
Thu / Aug 12th
The U.S. Food and Drug Administration has denied two applications from companies seeking to sell CBD hemp extracts as a dietary supplement because CBD is an approved drug.
Wed / May 5th
The FDA has announced plans to ban flavored tobacco products including menthol cigarettes and flavored cigars.
Mon / Dec 28th
The FTC and FDA have launched “Operation CBDeceit,” sending fines and warning letters to CBD companies who allegedly made false or misleading health claims about their products.
Tue / Aug 18th
The FDA announced it is hiring a third-party contractor to test CBD “and related cannabinoids” for the agency.
Mon / Aug 3rd
The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.
Wed / Jul 22nd
The FDA has opened public comments for new preliminary guidance from the agency for cannabis pharmaceutical research.
Tue / Jun 9th
The FTC has filed a rare lawsuit against CBD company Whole Leaf Organics over unfounded treatment claims made by the company.
Mon / May 18th
Summitt Labs announced last week it was voluntarily recalling Batch#730 Lot#K018 of its Kore Organic Watermelon CBD Oil Tincture.
Tue / Apr 28th
The FDA has issued warnings to two CBD companies over claims that their products could treat opioid addiction and/or replace pharmaceutical drugs.
Tue / Apr 21st
The Hemp Feed Coalition is submitting an application to get hemp approved as chicken feed by the FDA; the process could take 18 months or longer.
Thu / Jan 16th
Lawmakers questioned officials from the DEA, FDA, and National Institutes of Health yesterday about the federal limitations on cannabis research; Rep. Joe Kennedy III (D-MA) accused the government agencies of hiding behind a cannabis “Catch-22.”
Wed / Nov 27th
A new FDA consumer update claims that CBD “has the potential to harm” and suggests that symptoms could range from potential mood swings to even male infertility.
Tue / Nov 26th
Senate Majority Leader Mitch McConnell recently met with FDA Commissioner nominee Dr. Stephen Hahn and discussed the need for a federal CBD regulatory framework.
Tue / Nov 12th
The FDA has approved a human trials study by the Yale School of Medicine and CT Pharma investigating the effectiveness of cannabis-based medicines; it’s the first cannabis study on human subjects to be approved by the FDA.
Tue / Sep 10th
Researchers at Johns Hopkins University announced last week the formation of what is likely the world’s largest research facility dedicated to psilocybin and psychedelic medicinal research.
Fri / Aug 16th
Washington state Ag Department officials recently clarified that hemp-derived CBD is not allowed as a food additive.
Tue / Jul 16th
FDA officials say they will rush the release of federal CBD rules and regulations, potentially by the end of summer or early fall.
Tue / Jun 25th
Three weeks after its first public hearing on cannabidiol, the FDA says it will apply a “rigorous and science-based approach” to devising CBD regulations; however, despite the quickly growing marketplace, the agency has not yet set any official guidelines.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.